GBS

GBS Inc.

Price

return (12m)

0.00%

p/e

-43.82

p/bv

67.10

DIVIDEND YIELD

0.00%

GBS price

GBS

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GBS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals GBS

Valuation

P/E

-43.82

Sector -2.32

Industry 0.64

P/BV

67.10

Sector 2.20

Industry 2.34

P/Revenue (PSR)

0.81

Sector 1.98

Industry 2.36

EV/EBITDA

Sector -17.91

Industry -7.16

EV/EBIT

Sector -32.00

Industry -19.80

P/EBITDA

-51.38

Sector 0.65

Industry 1.89

P/EBIT

-51.38

Sector -2.86

Industry -0.28

P/Total Assets

34.88

Sector 1.21

Industry 1.33

P/Net Current Assets

Sector -10.77

Industry -13.73

P/Working Capital

Sector -4.09

Industry 3.26

EPS

-0.54

Sector -0.86

Industry -0.71

BVPS

0.35

Sector 3.90

Industry 4.96

Efficiency

Gross Margin

0.00%

Sector 44.00%

Industry 49.18%

EBITDA Margin

Sector -331.60%

Industry -50.78%

EBIT Margin

0.00%

Sector -188.01%

Industry -50.20%

Operating Margin

-100.00%

Sector -24.42%

Industry -27.39%

Net Profit Margins

-1.85%

Sector -28.72%

Industry -31.17%

Asset Turnover

0.03

Sector 0.12

Industry 0.15

Profitability

ROE

-153.14%

Sector -33.72%

Industry -32.25%

ROA

-79.60%

Sector -29.12%

Industry -27.28%

ROIC

Sector -416.63%

Industry -95.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.84

Industry 1.99

Net Debt / EBITDA

Sector 0.20

Industry -3.17

Net Debt / EBIT

Sector -1.28

Industry -1.91

Net Debt / Equity

Sector -0.37

Industry -0.32

Gross Debt / Equity

Sector 0.16

Industry -0.90

Equity/Assets

0.52

Sector 0.42

Industry 0.45

Liabilities/Assets

0.52

Sector 0.46

Industry 0.50

Growth

5Y Revenue CAGR

554.47%

Sector -

Industry -

5Y Earnings CAGR

-1.84%

Sector -

Industry -

Fundamentals GBS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GBS GBS Inc.	$0.00	-	0.00%	-43.82	67.10	-153.14%	-1.85%
ISRG Intuitive Surgical Inc.	$401.27	-16.09%	0.00%	42.46	7.28	17.15%	28.45%
ABT Abbott Laboratories	$111.27	-11.57%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$90.58	1.56%	3.31%	22.98	2.20	9.59%	13.20%
BSX Boston Scientific Corp.	$51.69	-49.57%	0.00%	17.89	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$89.64	-31.64%	0.00%	18.66	5.46	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$566.93	-13.08%	0.00%	40.91	28.91	70.67%	25.03%
RMD ResMed Inc.	$226.74	-18.92%	1.15%	19.82	4.58	23.13%	26.94%
SYK Stryker Corp.	$341.09	-8.27%	1.03%	34.67	5.39	15.55%	14.43%
PHG Koninklijke Philips NV	$27.37	5.38%	3.80%	19.68	1.93	9.80%	6.30%
COHR Coherent Inc.	$327.23	180.74%	0.00%	157.51	6.70	4.26%	7.10%
INMD InMode Ltd.	$15.20	6.89%	0.00%	11.60	1.43	12.32%	20.69%
DXCM DexCom Inc.	$91.48	14.11%	0.00%	32.09	12.24	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.56	20.32%	0.00%	51.30	4.81	9.37%	15.43%
IMRA Imara Inc.	$14.59	-62.60%	92.02%	65.05	1.13	1.74%	0.00%
BDX Becton Dickinson and Company	$181.97	-3.77%	2.40%	51.01	1.97	3.85%	4.05%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$176.20	20.90%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
SNN Smith & Nephew PLC	$30.13	-14.03%	2.59%	11.25	2.45	21.74%	9.20%
IRMD iRadimed Corporation	$87.16	21.06%	1.34%	52.12	11.81	22.66%	26.71%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GBS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT GBS

GBS Inc.

Average Investor10 user rating

4.0 (0 people)

United States

10 years

Founded: 2016

2020

Time since IPO - 6 years

5

Employees

GBS Inc. (United States) is listed on the Nasdaq and has a market capitalization of $354.38 million, with shareholders equity totaling $5.28 million.

The company employs approximately 5 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, GBS Inc. reported $437.65 million in revenue, generating net income of $-8.09 million.

Key financial metrics include a P/E ratio of -43.82, a price-to-book (P/B) ratio of 67.10, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GBS.

Market cap

$354.38 million

Net worth

$5.28 million

$5,281,070.00

Assets

$10.16 million

$10,159,703.00

Total Shares Outstanding

14.89 million

14,889,000

Average Daily Trading Volume

$3.62 million

$3,617,361.78

Sector

Health

Industry

Medical Supplies and Equipment

GBS

GBS revenue and profits

Financial Results GBS

DRAG THE FRAME TO SEE MORE DATA

GBS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$94.99 46,85% (12M)

P/E

24.95

2.79%

ROE

6.12%

P/BV

1.53

CI - Cigna

$277.99 --1,60% (12M)

P/E

10.74

2.21%

ROE

16.04%

P/BV

1.72

CNC - Centene

$66.05 145,27% (12M)

P/E

-6.36

0.00%

ROE

-22.51%

P/BV

1.43

HUM - Humana

$384.97 38,81% (12M)

P/E

35.81

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$43.78 --7,21% (12M)

P/E

7.07

4.06%

ROE

18.43%

P/BV

1.30

LLY - Eli Lilly

$1,209.00 73,90% (12M)

P/E

39.20

0.55%

ROE

78.84%

P/BV

30.91

HCA - HCA Healthcare

$411.74 5,28% (12M)

P/E

13.27

0.73%

ROE

-213.15%

P/BV

-28.28

NVS - Novartis

$151.72 26,68% (12M)

P/E

23.30

1.99%

ROE

30.41%

P/BV

7.09